"Consider your pharmacist at Lifespan Pharmacy as part of your health care team. We communicate with your physician to provide comprehensive, safe care. Our experienced pharmacy representatives are specially trained to assist you with everything from answering commonly asked questions about your medication to medication delivery."

During the past decade, Rhode Island Hospital-Pharmacy Service conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rhode Island Hospital-Pharmacy Service" are "Anemia, Sickle Cell" (1 trials), "Pain Crisis" (1 trials), "Sickle Cell Anemia" (1 trials), "Sickle Cell Disease" (1 trials) and "Sickle Cell Disorders" (1 trials). Many other conditions were trialed in "Rhode Island Hospital-Pharmacy Service" in a lesser frequency.

Most popular intervention types in "Rhode Island Hospital-Pharmacy Service" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rivipansel" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rhode Island Hospital-Pharmacy Service" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rhode Island Hospital-Pharmacy Service". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rhode Island Hospital-Pharmacy Service, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rhode Island Hospital-Pharmacy Service, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".